Related Experiment Videos

Drug dosage in children with reduced renal function

Markus Daschner1

  • 1Division of Paediatric Nephrology, University Children's Hospital, Heidelberg, Germany. markus_daschner@med.uni-heidelberg.de

Pediatric Nephrology (Berlin, Germany)
|September 1, 2005
PubMed

Insights

Estimating drug doses for children with kidney problems is complex. This review offers guidelines for paediatric nephrology and neonatology to improve medication accuracy in young patients with renal failure.

Area of Science:

  • Pediatric Nephrology
  • Neonatology
  • Clinical Pharmacology

Background:

  • Accurate drug dosing in pediatric nephrology is challenging due to multiple factors, leading to potential errors.
  • Immature renal function in neonates and premature infants complicates medication management.

Purpose of the Study:

  • To consolidate drug dose adjustment guidelines for pediatric patients with renal failure.
  • To integrate information on neonatal and premature infant renal function for improved drug dosing.
  • To assist pediatric nephrologists and neonatologists in estimating accurate drug doses.

Main Methods:

  • Systematic review of existing pediatric nephrology dose adjustment guidelines.
  • Compilation of data on renal function in neonates and premature infants.
  • Synthesis of information to create practical dosing recommendations.

Main Results:

  • A comprehensive set of dose adjustment guidelines for pediatric renal failure.
  • Key considerations for drug dosing in immature renal systems.
  • Facilitation of accurate drug dose estimation for neonatologists and pediatric nephrologists.

Conclusions:

  • This review provides essential resources for optimizing drug therapy in pediatric patients with kidney disease.
  • Improved drug dosing strategies can enhance patient outcomes and reduce adverse events in neonatology and pediatric nephrology.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...